(1)
Blauvelt, A. .; Eichenfeld, L.; Kuligowski, M.; Venturanza, M.; Sun, K.; Silverberg, J. Long-Term Safety and Disease Control With Ruxolitinib Cream Among Patients With Atopic Dermatitis Based on Previous Medication History: Pooled Results from Two Phase 3 Studies. J of Skin 2021, 5, s65.